US 6811782
Peptide composition as immunogen for the treatment of allergy
expired A61KA61K2039/6075A61K2039/6081
Quick answer
US patent 6811782 (Peptide composition as immunogen for the treatment of allergy) held by United Biomedical, Inc. expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- United Biomedical, Inc.
- Grant date
- Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/6075, A61K2039/6081, A61K38/00, A61K39/0008